Podcasts

Our selection of trials, registry data and guideline updates from the 2014 European Society of Cardiology (ESC) Congress. Dr Christopher Cannon focuses on the ODYSSEY programme, and adherence issues with PCSK9 monoclonal antibody therapies. Professor Kausik Ray puts the key studies into clinical perspective, and explains why the extent – not the means – of LDL cholesterol lowering is key in the prevention of CVD.

Our selection of trials, registry data and guideline updates from the 2014 European Society of Cardiology (ESC) Congress. Professor Kausik Ray puts the key studies into clinical perspective, and explains why the extent – not the means – of LDL cholesterol lowering is key in the prevention of CVD.

Highlights of studies presented at the 2014 European Atherosclerosis Society Congress. Professor Jane Armitage discusses new lipid treatments for managing CV risk, and existing therapies to lower LDL cholesterol. Professor Gerald Watts discuss the International Familial Hypercholesterolaemia Foundation guidelines.

Highlights from the 2013 European Society of Cardiology (ESC) Congress. Dr Henry Oluwasefunmi Savage discusses the GARFIELD registry, and the SERVE-HF study.

Dr Henry Oluwasefunmi Savage, Royal Brompton Hospital, London, discusses:

• The GARFIELD registry in AF
• SERVE-HF study looking at sleep apnoea

Highlights from the 2013 European Society of Cardiology (ESC) Congress. Dr Terry McCormack discusses the EXAMINE and SAVOR-TIMI 53 studies, edoxaban, the RE-ALIGN study and the EHRA practical guide to the use of the new oral anticoagulants.

Dr Terry McCormack, Whitby GP and BJC editor, discusses:

• The EXAMINE and SAVOR-TIMI 53 studies looking at the cardiovascular effects of the gliptins in type 2 diabetes
• HOKUSAI-VTE and edoxaban, a new oral anticoagulant, in VTE
• RE-ALIGN and the use of anticoagulants in heart valve disease
• The EHRA practical guide to the use of the new oral anticoagulants
• PREFER-AF registry in AF

Highlights from the 2013 European Society of Cardiology (ESC) Congress. Dr Paul Kalra discusses the ESC Guidelines on stable coronary artery disease, the ECHO-CRT trial, and primary PCI in STEMI patients.

Dr Paul Kalra, Portsmouth Hospitals NHS Trust, discusses:

• ESC Guidelines on stable coronary artery disease
• ECHO-CRT looking at cardiac resynchronisation therapy in severe heart failure
• PRAMI and primary PCI in STEMI patients